Meijuan Li
- Biological Psychiatry top 10%
- Tryptophan and brain disorders 10
-
- Traditional Chinese Medicine Analysis 6
- Pharmacology top 5%
- Treatment of Major Depression 4
-
- Treatment of Major Depression 4
-
- Schizophrenia research and treatment 8
- Bipolar Disorder and Treatment 5
-
- Metabolomics and Mass Spectrometry Studies 4
-
- Child and Adolescent Psychosocial and Emotional Development 4
-
- Fatty Acid Research and Health 4
- Journals
- Journal of Clinical Oncology (2 papers)Cancer Research (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Meijuan Li
56 papers receiving 594 citations
Peers
Comparison fields: 5 of 103
- Biological Psychiatry 32
- Complementary and alternative medicine 102
- Pharmacology 83
- Microbiology 24
- Pharmacology 62
Countries citing papers authored by Meijuan Li
This map shows the geographic impact of Meijuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meijuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meijuan Li more than expected).
Fields of papers citing papers by Meijuan Li
This network shows the impact of papers produced by Meijuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meijuan Li. The network helps show where Meijuan Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meijuan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 14 | |
| 13 | 2022 | 12 | |
| 14 | 2021 | 13 | |
| 15 | 2021 | 14 | |
| 16 | 2020 | 8 | |
| 17 | 2016 | 40 | |
| 18 | 2015 | 40 | |
| 19 | 2013 | 10 | |
| 20 | 2013 | 46 |
About Meijuan Li
Meijuan Li is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Behavioral Neuroscience, having authored 61 papers that have together received 598 indexed citations. Recurring topics across this work include Tryptophan and brain disorders (10 papers), Schizophrenia research and treatment (8 papers), Traditional Chinese Medicine Analysis (6 papers), Bipolar Disorder and Treatment (5 papers), Metabolomics and Mass Spectrometry Studies (4 papers), Child and Adolescent Psychosocial and Emotional Development (4 papers), Fatty Acid Research and Health (4 papers) and Treatment of Major Depression (4 papers). The work is most often cited by research in Biological Psychiatry (32 citations), Complementary and alternative medicine (102 citations) and Pharmacology (83 citations). Meijuan Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include F. Xu, Feifei Du, Chen Cheng, Olajide E. Olaleye, Weiwei Jia, Yan Sun, Huachun Zou, Chuan Li, Jie Li and Guiying Hu. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.